Influence of conditioning regimens and stem cell sources on donor-type chimerism early after stem cell transplantation

Annals of Hematology

Volumn 87, Issue 12, 2008, Pages 1003-1008

  Sugita, Junichi ^a   Tanaka, Junji ^a   Hashimoto, Aya ^a   Shiratori, Souichi ^a   Yasumoto, Atsushi ^a   Wakasa, Kentaro ^a   Kikuchi, Misato ^a   Shigematsu, Akio ^a   Miura, Yoko ^a   Tsutsumi, Yutaka ^b   Kondo, Takeshi ^a   Asaka, Masahiro ^a   Imamura, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hakodate Municipal Hospital   (Japan)

Author keywords

Chimerism; Conditioning regimen; Microsatellite; Stem cell source

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUDARABINE; METHOTREXATE; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD DONOR; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; DIRECTED TISSUE DONATION; FEMALE; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; NEUTROPHILS; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 55649105855     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0542-4     Document Type: Article

References (25)

1. Balon J, Halaburda K, Bieniaszewska M, Reichert M, Bieniaszewski L, Piekarska A et al (2005) Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease. Bone Marrow Transplant 35:1083-1088 doi: 10.1038/sj.bmt.1704962
2. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE (2003) Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 102:1915-1919 doi: 10.1182/blood-2002-11-3337
3. Baron F, Sandmaier BM (2006) Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning. Leukemia 20:1690-1700 doi: 10.1038/sj.leu.2404335
4. Champlin R, Khouri I, Shimoni A, Gajewski J, Kornblau S, Molldrem J et al (2000) Harnessing graft-versus-malignancy: Non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy. Br J Haematol 111:18-29 doi: 10.1046/j.1365-2141.2000.02196.x
5. Childs R, Clave E, Contentin N, Jayasekera D, Hensel N, Leitman S et al (1999) Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses. Blood 94:3234-3241
6. Galimberti S, Benedetti E, Morabito F, Fazzi R, Pacini S, Andreazzoli F et al (2005) Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting. Transpl Immunol 15:173-177 doi: 10.1016/j.trim.2005.06.002
7. Giralt S, Thall PF, Khouri I, Wang X, Braunschweig I, Ippolitti C et al (2001) Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 97:631-637 doi: 10.1182/blood.V97.3.631
8. Gleissner B, Blau IW, Sindram A, Reinhardt R, Knauf W, Thiel E (2001) Analysis of chimerism during the early period after allogeneic peripheral stem cell transplantation. Clin Lab Haematol 23:401-406 doi: 10.1046/j.1365-2257.2001.00408.x
9. Huisman C, de Weger RA, de Vries L, Tilanus MG, Verdonck LF (2007) Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia. Bone Marrow Transplant 39:285-291 doi: 10.1038/sj.bmt.1705582
10. Jaksch M, Uzunel M, Remberger M, Sundberg B, Mattsson J (2005) Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II-IV. Clin Transplant 19:346-349 doi: 10.1111/j.1399-0012.2005.00345.x
11. Keil F, Prinz E, Moser K, Mannhalter C, Kalhs P, Worel N et al (2003) Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival. Transplantation 76:230-236 doi: 10.1097/01.TP.0000071862.42835.76
12. Kusumi E, Kami M, Yuji K, Hamaki T, Murashige N, Hori A et al (2004) Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor. Bone Marrow Transplant 33:697-702 doi: 10.1038/sj.bmt.1704425
13. Lassaletta A, Ramirez M, Montero JM, Gonzalez-Vicent M, Balas A, Madero L et al (2005) Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with hematological malignancies. Leukemia 19:504-506
14. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351:2265-2275 doi: 10.1056/NEJMoa041276
15. McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al (2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97:3390-3400 doi: 10.1182/ blood.V97.11.3390
16. Miura Y, Tanaka J, Toubai T, Tsutsumi Y, Kato N, Hirate D et al (2006) Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non-myeloablative stem cell transplantation. Bone Marrow Transplant 37:837-843 doi: 10.1038/ sj.bmt.1705352
17. Petersen SL, Madsen HO, Ryder LP, Svejgaard A, Masmas TN, Dickmeiss E et al (2004) Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease. Biol Blood Marrow Transplant 10:337-346 doi: 10.1016/j.bbmt.2004.01.003
18. Ritchie DS, Morton J, Szer J, Roberts AW, Durrant S, Shuttleworth P et al (2003) Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan. Biol Blood Marrow Transplant 9:435-442 doi: 10.1016/ S1083-8791(03)00128-9
19. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al (2004) Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351:2276-2285 doi: 10.1056/NEJMoa041469
20. Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 91:756-763
21. Stem cell Trialists' Collaborative Group (2005) Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials. J Clin Oncol 23:5074-5087
22. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y et al (2004) Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 104:3813-3820 doi: 10.1182/ blood-2004-03-1001
23. Tsutsumi Y, Tanaka J, Kato N, Zhang L, Mori A, Kobayasi R et al (2002) Analysis of mixed chimerism in patients after allogeneic stem cell transplantation using a capillary electrophoresis system. Acta Haematol 107:195-202 doi: 10.1159/000058314
24. Tsutsumi Y, Tanaka J, Sugita J, Kato N, Zhang L, Yonezumi M et al (2002) Analysis of T-cell repertoire and mixed chimaerism in a patient with aplastic anaemia after allogeneic bone marrow transplantation. Br J Haematol 118:136-139 doi: 10.1046/j.1365-2141.2002.03628.x
25. Valcarcel D, Martino R, Caballero D, Mateos MV, Perez-Simon JA, Canals C et al (2003) Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant 31:387-392 doi: 10.1038/sj.bmt.1703846